Search
Font size
- 1 2 3 + Font size

click to adjust

Page tools
Grants for Targets
Clinical Trials
tagcould

News


03/11/10, General Medicine FDA Grants Orphan Drug Status to Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis Berlin, March 11, 2010 – Bayer Schering Pharma AG, Germany, announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration (FDA) for the ciprofloxacin... more

IMI-Logo IMI – Innovative Medicines Initiative EMTRAIN: European platform for new educational and training programs in pharmaceutical medicine. more  

http://bayerscheringpharma.de/scripts/pages/en/index.php

Copyright © Bayer Schering Pharma AG